Ger-e-Tec: Development of a Codified Preventive Approach for the Management of the Main Geriatric Risks

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05128097
Collaborator
(none)
107
Enrollment
1
Location
19
Anticipated Duration (Months)
5.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Nowadays, EHPAD residents are polypathological (cognitive and psycho-behavioral pathologies, undernutrition, IC, diabetes, COPD, IR, etc.) and multi-medicated. From a medical point of view, this implies the need for regular monitoring and a high level of medical or even multidisciplinary expertise for the healthcare team. The objective of the GER-e-TEC ™ project is to provide these complex patients with telemedicine tools allowing protocolized and personalized, non-intrusive monitoring. The GER-e-TEC ™ project more specifically takes into account the significant issues in nursing homes of aging residents with the main geriatric syndromes (fall, undernutrition, cognitive-behavioral disorders, iatropathogeny, etc.) The objective of the work undertaken is to develop a codified preventive approach for the management of the main geriatric risks, in order to avoid the occurrence of an acute decompensation factor in the elderly.

Condition or DiseaseIntervention/TreatmentPhase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    107 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Development of a Codified Preventive Approach for the Management of the Main Geriatric Risks
    Actual Study Start Date :
    Jun 1, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2021
    Anticipated Study Completion Date :
    Dec 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective study of the management of the main geriatric risks in the University HÔptaux de Strasbourg [Files analysed retrospectively from from June 17, 2019 to November 13, 2019 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:
    • Major subject (≥65 years old)

    • Subject hospitalized between June 17, 2019 to November 13, 2019, in the UF 3723 department, of the Medical Clinic B of the University Hospitals of Strasbourg

    • Having not expressed his opposition, after information, to the reuse of his data for the purposes of this research.

    Exclusion criteria:
    • Subject having expressed opposition to participating in the study

    • Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, etc.)

    • Subject under guardianship or guardianship

    • Subject under safeguard of justice

    • Subject in palliative / end of life situation

    • Subject in acute emergency situation

    Contacts and Locations

    Locations

    SiteCityStateCountryPostal Code
    1Médecine interne, Diabète, et Maladies Métaboliques - Hôpitaux Universitaires de StrasbourgStrasbourgFrance

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Emmanuel ANDRES, MD, PhD, Médecine interne, Diabète, et Maladies Métaboliques - Hôpitaux Universitaires de Strasbourg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05128097
    Other Study ID Numbers:
    • 7792
    First Posted:
    Nov 19, 2021
    Last Update Posted:
    Nov 19, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 19, 2021